Cite

HARVARD Citation

    Shi, W. et al. (2021). A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine. Cancer letters. pp. 184-197. [Online]. 
  
Back to record